Cohance Lifesciences Ltd.

₹542.2

- 6.90 (-1.26%)

04:01 pm - close price

BSE: COHANCE

NSE: COHANCE

Industry: Pharmaceuticals & Drugs

House: Private

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 10.52Good: 5

✅

Adjusted EPS

Bad: 3Current: 10.52Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 18.44Good: 20

🟡

Current Ratio

Bad: 1Current: 2.34Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 14.20Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 2.58Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 10.52Good: 5

✅

Adjusted EPS

Bad: 3Current: 10.52Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 18.44Good: 20

🟡

Current Ratio

Bad: 1Current: 2.34Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 14.20Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 2.58Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	347.55	231.05	219.82	252.93	230.69
Expenditure+	179.80	133.09	154.68	179.59	150.76
Other Income+	10.67	19.84	14.34	17.05	18.16
Operating Profit	167.75	97.96	65.14	73.34	79.93
Interest	1.86	0.50	1.27	2.30	1.60
Depreciation and Amortization	12.61	11.89	12.75	17.25	13.40
Profit Before Tax	163.95	105.41	65.47	70.85	83.09
Tax+	43.35	25.84	18.71	17.48	22.32
Net Profit	120.60	79.56	46.75	53.37	60.77

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	100971.85	132022.21	134032.88	1051.35	1197.58
Operational Expenses+	56671.63	73850.02	76616.55	645.54	822.38
Operating Profit	44300.22	58172.19	57416.33	405.81	375.20
Other Income	1423.70	9238.03	4636.38	61.91	58.56
OPM %	43.87	44.06	42.84	38.60	31.33
Depreciation and Amortisation	3163.58	3909.72	4798.64	54.60	77.49
Interest	1166.53	852.75	1281.09	7.45	12.35
Profit Before Tax	46767.41	66758.98	55972.98	405.67	343.92
Tax	10515.48	21378.49	15061.18	106.17	72.58
Net Profit	36234.18	45380.49	41129.03	300.28	267.87

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	157622.28	196681.33	211006.54	2254.10	3031.20
Liabilities+	157622.28	196681.33	211006.54	2254.10	3031.20

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	38254.65	33000.02	45719.58	384.77	288.16
Cash from Investing Activity	-31139.82	-13613.83	-19500.56	-362.35	-255.30
Cash from Financing Activity	-7566.17	-15648.07	-24195.12	-39.99	3.32
Net Cash Flow	-451.34	3738.12	2023.90	-17.57	36.18
Opening Cash & Cash Equivalents	1169.54	718.22	4456.38	64.80	47.23
Closing Cash & Cash Equivalents	718.23	4456.38	6480.28	47.23	85.40

Shareholder Pattern

In %	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23	JUN'23
Promoters+	57.49	66.41	50.10	50.10	50.10	50.10	50.10	60.00	60.00	60.00
Public+	42.51	33.59	49.90	49.90	49.90	49.90	49.90	40.00	40.00	40.00
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	75284	80910	86325	84210	69337	65777	68932	70052	73715	72167

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	38254.65	33000.02	45719.58	384.77	288.16
Cash from Investing Activity	-31139.82	-13613.83	-19500.56	-362.35	-255.30
Cash from Financing Activity	-7566.17	-15648.07	-24195.12	-39.99	3.32
Net Cash Flow	-451.34	3738.12	2023.90	-17.57	36.18
Opening Cash & Cash Equivalents	1169.54	718.22	4456.38	64.80	47.23
Closing Cash & Cash Equivalents	718.23	4456.38	6480.28	47.23	85.40

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	100971.85	132022.21	134032.88	1051.35	1197.58
Operational Expenses+	56671.63	73850.02	76616.55	645.54	822.38
Operating Profit	44300.22	58172.19	57416.33	405.81	375.20
Other Income	1423.70	9238.03	4636.38	61.91	58.56
OPM %	43.87	44.06	42.84	38.60	31.33
Depreciation and Amortisation	3163.58	3909.72	4798.64	54.60	77.49
Interest	1166.53	852.75	1281.09	7.45	12.35
Profit Before Tax	46767.41	66758.98	55972.98	405.67	343.92
Tax	10515.48	21378.49	15061.18	106.17	72.58
Net Profit	36234.18	45380.49	41129.03	300.28	267.87

Ratios

Reported EPS

Bad: 2Current: 10.52Good: 5

✅

Adjusted EPS

Bad: 3Current: 10.52Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 18.44Good: 20

🟡

Current Ratio

Bad: 1Current: 2.34Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 14.20Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 2.58Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 10.52Good: 5

✅

Adjusted EPS

Bad: 3Current: 10.52Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 18.44Good: 20

🟡

Current Ratio

Bad: 1Current: 2.34Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 14.20Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 2.58Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	347.55	231.05	219.82	252.93	230.69
Expenditure+	179.80	133.09	154.68	179.59	150.76
Other Income+	10.67	19.84	14.34	17.05	18.16
Operating Profit	167.75	97.96	65.14	73.34	79.93
Interest	1.86	0.50	1.27	2.30	1.60
Depreciation and Amortization	12.61	11.89	12.75	17.25	13.40
Profit Before Tax	163.95	105.41	65.47	70.85	83.09
Tax+	43.35	25.84	18.71	17.48	22.32
Net Profit	120.60	79.56	46.75	53.37	60.77

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	157622.28	196681.33	211006.54	2254.10	3031.20
Liabilities+	157622.28	196681.33	211006.54	2254.10	3031.20

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Shareholder Pattern

In %	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23	JUN'23
Promoters+	57.49	66.41	50.10	50.10	50.10	50.10	50.10	60.00	60.00	60.00
Public+	42.51	33.59	49.90	49.90	49.90	49.90	49.90	40.00	40.00	40.00
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	75284	80910	86325	84210	69337	65777	68932	70052	73715	72167

Cohance Lifesciences Ltd.

₹542.2

- 6.90 (-1.26%)

04:01 pm - close price

BSE: COHANCE

NSE: COHANCE

Industry: Pharmaceuticals & Drugs

House: Private

Overview